Fink Jeffrey Arvin 4
4 · Lipocine Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Fink Jeffrey Arvin
Director
Transactions
- Award
Common Stock (Right to Buy)
2025-06-04$3.20/sh+1,764$5,645→ 11,526 totalExercise: $3.20From: 2026-06-04Exp: 2035-06-04→ Common Stock (1,764 underlying)
Footnotes (1)
- [F1]100% vesting upon one year from date of grant.